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SUMMARY
Obstruction of the rabbit ureter appears to alter the basic
physiologic mechanisms governing beta-inhibitory adrenergic media¬
tion of ureteral smooth muscle relaxation.

Obstructed ureters

were relatively insensitive to isoproterenol in comparison to
unobstructed controls.

The potassium depolarized obstructed ureters

developed a greater force of contraction than did the controls;
however, the degree of contractility was not a factor in the in¬
sensitivity of obstructed ureters to isoproterenol.

Theophylline,

a phosphodiesterase inhibitor, caused a marked relaxation of both
obstructed and unobstructed ureters.

Furthermore, obstructed

ureters which were contracted with a depolarizing concentration of
potassium in the presence of theophylline were able to be relaxed
when exposed to isoproterenol.
Biochemical studies were in accord with the mechanical data.
Basal adenylate cyclase activity of obstructed ureters was decreased
and endogenous cAMP levels did not increase with administration
of isoproterenol.

Phosphodiesterase activity of obstructed ureters

was less than that noted in the unobstructed controls.
One possible explanation for these results is a possible
defect in the beta-inhibitory receptor-adenylate cyclase link of
obstructed ureteral smooth muscle.

Alternatively, compartmentalization

of phosphodiesterase in the obstructed ureters may allow sufficient
levels of the enzyme to break down cAMP below a "threshold" level
that is required for relaxation.

i|

INTRODUCTION

The question as to whether the autonomic nervous system
has a role in control of ureteral function has been the subject
of considerable debate.

Recent studies have suggested that there

are alpha stimulatory and beta inhibitory adrenergic receptors
in the ureter.

Isoproterenol, a beta-adrenergic agonist, has

been shown to decrease ureteral contractility.

Propranol, a beta

blocker, has been shown to reverse the effect of isoproterenol.
Beta-adrenergic induced relaxation of smooth muscle mv be

,

mediated by cAMP (30, 31

32).

Weiss and associates (60) have

demonstrated that rabbit ureters have beta adrenergic receptors
and an adenylate cyclase-phosphodiesterase system.

They showed

that isoproterenol stimulated adenylate cyclase and that theophyl¬
line increased cAMP by inhibiting phosphodiesterase.

Hausman

et al. (6l) obstructed rabbit ureters and noted increases in
ureteral contractility of the obstructed ureteral segments upon
electrical stimulation.

The observed increase in developed force

was greater than that which would be by muscular hypertrophy
alone.
The present investigation was designed to examine the effects
of acute obstruction on beta-inhibitory receptor stimulation
of the ureter by isoproterenol.

Specifically, changes in the

relaxation characteristics of obstructed ureters in response to

5

beta-inhibitory receptor stimulation were correlated with adeny¬
late cyclase activity, phosphodiesterase activity and cAMP levels.
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Adrenergic Influences on Ureteral Function

The primary function of the mammalian ureter is to channel
urine from the kidney into the bladder.

This relatively simple

task involves complex physiologic mechanisms which are still under
considerable debate.

Currently it is believed that electrically

active pacemaker regions in the proximal portion of the upper
urinary tract trigger action potentials.

These electrical impulses

are relayed distally via the intercellular conduction of the
action potentials.

The mechanical end result is a peristatic wave

pattern which moves the bolus of urine toward the bladder.

The

uretero-vesical junction acts to prevent retrogra.de reflux and
ensures antegrade urine flow.
During intra-abdominal procedures, many surgeons have noted
visible waves of ureteral peristalsis.

The question arose "what

controls these regular waves of ureteral contractions?"

In 19^8

there were proponents of a myogenic basis for the regulation of
ureteral peristalsis.

It was postulated that tonus and rhythmic

contractions of the intact human ureter were independent of the
nervous system.

Furthermore, the major stimulus for initiation of

a peristaltic wave was thought to be the urine flow from the
kidney which stretched the smooth muscle fibers of the ureter.
A pharmacologic evaluation of drugs which affect the central
nervous system including the autonomic nervous system revealed
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little direct effect on ureteral peristalsis (1).

The only changes

in ureteral function resulting from these agents were attributed
to changes in urine flow.
Further evidence in support of the myogenic theory was provided
in a study which utilized an ureteroureteral anastomosis of a
denervated dog kidney in a transplantation procedure.

The dener¬

vation of the ureter did not interfere with the persistence of
regular peristaltic activity (2).

In another study, a segment

from the midportion of the pig ureter was excised, its direction
reversed and then reanastomosed without affecting pressure wave
patterns, intraureteral pressure or kidney function.

The per¬

sistence of antegrade peristalsis suggested that the propulsion of
urine was entirely a myogenic function (3)•
There is however increasing recent evidence that suggests
that although the autonomic nervous system is not necessary for
peristalsis, it may modify the character of ureteral peristalsis.
Boyarsky et al. electrically stimulated the renal, nerves and
observed an increase in ureteral peristalsis frequency (4).
Furthermore, he stressed that the ureter had both alpha stimulatory
and beta inhibitory adrenergic receptors which responded approp¬
riately to adrenaline, noradrenaline, isoproterenol and phenyl¬
ephrine.

A high catecholamine content was also demonstrated in

the ureter but the workers conceded they could not differentiate
between vascular and muscular localization of these catecholamines
(5).

Other researchers have provided apparent histochemical
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evidence of adrenergic and cholinergic fibers in close apposition
to ureteral smooth muscle fibers (6).
Longrigg et al. postulated that the response of smooth mus¬
cle preparations of human minor calycies to short duration electric¬
al stimuli, which were subthreshold for direct smooth muscle
excitation, resulted from the liberation of noradrenaline.

The

catecholamines were thought to be released from postganglionic
sympathetic nerves present within the ureteral tissue which sub¬
sequently combined with adrenergic receptors.

Alpha blockade with

phentolamine decreased the response to these short duration elec¬
trical impulses (7).

Weiss observed that electrical stimuli that

were subthreshold for direct muscle excitation also affected the
contractile force generated by isolated segments of rabbit ureter
by apparently exciting autonomic nerve endings within the ureteral
tissue (8).
Much of the confusion in the data regarding adrenergic in¬
fluences of the ureter has been derived from the varying techniques
utilized by various investigators.

Early in vivo techniques

measured changes in urine flow rather than the ureteral peris¬
talsis (9).

Later workers used indwelling pressure catheters

which according to Dale et al. altered the regularity of peris¬
talsis (10).

Despite the inconsistency of the data, there is,

however, increasing evidence that there are indeed adrenergic
receptors in the ureter.

The role of these receptors in terms of

the ultimate control of ureteral function is still to be defined.
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Kaplan et al. investigated the effects of alpha and beta agonists
on the in situ ureter.

Although alpha receptor agonists increased

in situ peristalsis, beta agonists had no consistent effect on
tiie ureteral activity.

They concluded that the effects were due

to direct action of the agents on muscle cells and not via an
indirect reflex mechanism involving the autonomic nervous system
(11).

Boatman et al. conducted a similar study and also con¬

cluded that the in situ ureter had alpha receptor activity without
beta receptor response (12).

On the other hand, McLeod and

associates provided evidence that there were both alpha and betaadrenergic receptors in the intact dog ureter (13).

To ensure

that the observed effects of antonomic agents on ureteral function
were not due to changes in urine flow. Rose and Gillenwater
perfused the in vivo canine ureter at a constant rate.

They

found that adrenergic agents (epinephrine and norepinephrine)
increased the force of ureteral contractions and isoproterenol
(a beta agonist) decreased ureteral contractility (1^).

Tindall

recognized the inadequacy of some of the previous investigations
which disregarded the systemic physiologic effects of adrenergic
agents which could falsely alter ureteral activity.

He injected

the spermatic artery and his results indicate that the rat ureter
has alpha adrenergic activity at the distal end (15).

Furthermore,

Weiss and associates noted that the in vivo deformity of acutely
obstructed rabbit ureters were greatly enhanced by reserpine
which depleted catecholamines.
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They suggested that ureteral

tonus in an intact rabbit ureter was modified by adrenergic
activity (16).
The majority of workers have found that isoproterenol (beta
agonist) inhibits in vivo ureteral peristalsis (13, 14, 15, 17)
although here again some workers had not demonstrated a beta
effect on the ureter (12, 11).

In vitro studies on isolated ure¬

teral muscle strips have basically confirmed the in vivo evidence
that isoproterenol reduced ureteral peristalsis (8, 18).
Deane utilizing an isolated preparation of pig ureter demon¬
strated that alpha agonists increased motor activity whereas
beta agonists decreased the motility.
was blocked by propranalol (19).

The effect of isoproterenol

Weiss and associates studied

the in vitro effect of adrenergic agents on ureteral segments.
They demonstrated that electrical stimulation of ureteral muscle
strips were augmented by alpha agonists and depressed by beta
agonists (8).

The norepinephrine induced increase in force of

ureteral contractions was potentiated by propranalol and decreased
by phentolamine.

Malin et al. also demonstrated the presence of

alpha stimulatory and beta inhibitory adrenergic receptors in human
ureteral segments (18).
The role of parasympathetic innervation of the in vivo ureter
has not been defined.

Most of the recent work has been contra¬

dictory and it is generally believed that parasympathetic innerva¬
tion has little effect on ureteral smooth muscle (14).
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Basically the role of adrenergic innervation of the ureter
can be characterized as one of modulation.

It is conceded that

the ureter may function without any adrenergic influence.

The

recent evidence, however, suggests that there are alpha-stimulatory
and beta-inhibitory adrenergic receptors within the ureteral
musculature and they may influence the character of ureteral
motility.

Cyclic Nucleotides and Smooth Muscle Function

To understand the role of catecholamines on ureteral func¬
tion, the level of investigation must probe the basic physiologic
mechanisms involved at the cellular level.

During the decade

that led to increased awareness of adrenergic involvement in
ureteral peristalsis, researchers also were elucidating the role
of cyclic nucleotides in cellular function.

In what now is re¬

garded as one of the major breakthroughs in science during the
last two decades, Sutherland, Rail and associates elucidated
the enigma as to how epinephrine and glucagon were involved in
the process of glycogenolysis in a whole liver preparation.

They

+P
demonstrated that in the presence of ATP and Mg , epinephrine
and glucagon activated phosphorylase in a cell-free system, a
homogenate of rat liver (20).

This activation of phosphorylase

depended on the preliminary synthesis of a heat stable molecule,
adenosine 3'» 5’ monophosphate, cyclic AMP which was formed
when epinephrine and glucagon were added to the membrane containing
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components of the whole homogenate (21).

Additional work revealed

that cyclic AMP was synthesized by an enzyme adenylate cyclase
which is a structural component of the plasma membrane, which
converted ATP to cyclic AMP in the presence of Mg+^ (22).

Cyclic

AMP was found to be rapidly inactivated by an enzyme —- phospho¬
diesterase which disrupts the phosphate-ribose ring to produce
5"AMP (23).
From this work, Sutherland and his associates formulated
the second messenger concept.

Basically, the first messenger is

a hormone which travels from its own parent cell and is directed
towards a target cell.

In turn, once the first messenger reaches

the target cell it combines with a specific receptor site on the
outer membrane of the target cell.

This initiates the formation

of the second messenger, cyclic AMP, which evokes matabolic changes
appropriate for the target cell in response to the hormonal
stimulus (24).
Specifically in the case of the ureteral smooth muscle
an example of a first messenger is isoproterenol.

This beta

adrenergic agonist combines with the beta receptor site on the
external aspect of the plasma membrane of a ureteral smooth muscle
cell.

Adenylate cyclase, which is spatially linked in close

apposition to the beta receptor site is activated by the isopro¬
terenol beta receptor complex.

Although isoproterenol does not

directly enter the cell, its biologic effect is mediated via the
adenylate cyclase-cAMP system.
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Intracellulariiy produced cAMP

+2
synthesized in the presence of ATP and Mg
probably leads to the
activation of a protein kinase which is an important link in a
complex cascade system which eventually leads to the uptake of
Ca

by the sarcoplasmic reticulum.

The uptake of Ca

storage areas decreases cytoplasmic Ca

4-0

into

which then causes re¬

laxation of the smooth muscle.
The specific evidence that cyclic nucleotides are directly
involved in smooth muscle relaxation has not been clearly established.
What exists are a series of investigations which seem to fit some
of Sutherland’s criteria for cAMP media,tion of hormone action.
These criteria include that:

1) the hormone should activate

adenylate cyclase; 2) exogenous cAMP should mimic the effects
of the hormone on the tissue; 3) the increase in cAMP which follows
the application of a hormone should precede the functional events
of the responding tissue; and 4) inhibition of phosphodiesterase
should mimic or potentiate the functional response to the hormone
(25).

Effects of Adrenergic Drugs on Cell-free Preparations

Sutherland and Rail in 1961 proposed that epinephrine induced
relaxation of smooth muscle might be related to cAMP (26).

This

initial hypothesis failed to achieve experimental support when
Klainer et al. showed that although epinephrine caused an increase
in cAMP in a broken cell preparation of dog brain, it did not in¬
crease cAMP in dog aorta, femoral arteries, intestinal smooth
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muscle and guinea pig ileum and taenia coli (27).

However, in 1965,

Butcher, Ho, Meng and Sutherland showed that epinephrine Increased
cAMP in a broken cell preparation from the rat.

Bueding et al.

(1966) confirmed that physiologically active concentrations of
epinephrine caused an increase in cAMP in a fractionalized homogen¬
ate of guinea pig taenia coli,

a tissue that it also relaxed (29).

With this evidence, the idea that smooth muscle relaxation, at least
in some instances, was mediated by cyclic nucleotides gained consider¬
able attention.

The Effect of Adrenergic Drugs on Whole Muscle Preparations

Dobbs and Robison (1968) also postulated that beta adrenergic
receptor stimulation resulted in uterine smooth muscle relaxation.
Ihey noted that isoproterenol increased cAMP levels and relaxed
isolated uterine smooth muscle strips.

This effect was augmented

by theophylline and by dibutyryl cAMP.

Beta blocking agents inhibited

the effect of isoproterenol although the effects of theophylline were
unaffected (30).
Andersson and Mohme-Lundholm (1970) studied the metabolic
changes observed during relaxation of rabbit colon muscle by alpha
and beta adrenergic agonists.

Alpha-adrenergic stimulation was

followed by a decrease in cAMP, phosphorylase a activity and hexosephosphates.

Beta stimulation was followed by an increase in cAMP,

hexosephosphates, and lactate and by a decrease in ATP.

Beta block¬

ing agents inhibited these mechanical and metabolic effects induced
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by beta-adrenergic agonists.

The authors concluded that cAMP could

possibly mediate beta-adrenergic induced relaxation of rabbit colon
(31).
Polacek and Daniel (1971) noted that adrenaline induced relax¬
ation of isolated rat uteri was associated with an increase in
cAMP.

These effects of epinephrine could be blocked by propranolol

(beta blocker) but not by phenoxybenzamine (alpha blocker).
rise in cAMP occurred even in Ca

+?

free solution.

This

Hat uteri pre¬

treated with propranolol contracted in response to alpha-adrenergic
stimulation, an effect that was not associated with a change in
cAMP.

Uterine muscle strips pretreated with isoproterenol liad high

cAMP levels, however, in spite of the increase in cAMP, oxytocin
was still able to cause contractions.

The authors concluded that the

level of cAMP in the uterus was controlled by mechanisms related,
to the beta receptors and not the alpha receptors (32).
Verma and McNeil (1976) also noted that increases in cAMP
of rat uterine segments occurred after stimulation with isoproter¬
enol, histamine and tyramine.

The increase in cAMP observed with

all three drugs was blocked by propranolol.

The isoproterenol

induced relaxation and the increase in cAMP was thought to be due to
stimulation of beta-adrenergic receptors.

After depletion of

endogenous catecholamines with reserpine, histamine and tyramine
were unable to elevate tissue cAMP levels.

The authors concluded

that the effect of those two drugs were mediated by the release of
endogenous catecholamines (33).
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An important paper by Andersson and Nilsson provided data to
link smooth muscle relaxation with changes in cAMP and intracellular'
calcium.

They discovered a cAMP dependent Ca42 binding protein in

the microsomal fraction and they were also able to show that there
was a relationship between smooth muscle relaxation and an increase
in cAMP content. ' The authors proposed that an increase uptake of
calcium into intracellular storage sites and the resultant decrease
in free cytoplasmic Ca+2 caused smooth muscle relaxation (3*0*

This demonstration of a cAMP-dependent Ca+2 binding protein in
the microsomal fraction is a key finding in linking changes in
cAMP with smooth muscle relaxation, but it involved a tedious set
of experiments and to date it has not been duplicated by other

investigators.

Tomiyama (1975) confirmed that there was a Ca+2

binding microsoml fraction in guinea pig taenia coli, however,
cAMP did not increase uptake of Ca+2 by the fraction.

Tomiyama

suggested that the failure of cyclic AMP to accelerate Ca+2 uptake
could be due to the fact that there were several more unknown steps
in between the increase in cAMP content and smooth muscle relaxa¬
tion (35) •

The effects of angiotensin II and catecholamines on cAMP in
rat aorta and tail artery were studied by Volicer and Hyme (1971)*
Using labelled H3-AIP, catecholamines increased H3-AMP concentra¬
tions and this effect was blocked by propranolol.

The authors

could not explain the blocking effect of an alpha blocking agent on
the catecholamine induced increases in cAMP content (JS).
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Triner, Vulliemoz and Verosky (1972) were able to stimulate
adenylate cyclase of rat aorta and relax the muscle strips using
isoproterenol, epinephrine or norepinephrine in combination with
phentolamine.

Beta blocking agents antagonized the rise in cAMP and

the relaxing effects of the catecholamines (37).

Seidel (1975)

using beef coronary arteries confirmed the findings of previous
investigations that beta receptor stimulation resulted in vascular
smooth muscle relaxation (38).
Collins and Sutter (1975) were able to show that isoproterenol
was unable to relax rabbit anterior mesenteric portal veins in a
Na+-free solution despite increased levels in cAMP.

They theorized

that cAMP may be involved in isoproterenol induced relaxation
possibly acting via increased Na-Ca^ exchange mechanisms (39).
Recent work by Vulliemoz, Verosky and Triner demonstrated the effects
of synthetic beta adrenergic stimulants on the cAMP system in smooth
muscle.

The agents albuterol and terbutaline raised cyclic AMP levels

in rat uterus, aorta myocardium and dog bronchus and this effect was
blocked by beta antagonists.

Albuterol and terbutaline showed the

greatest effect in the bronchus but less effect in the myocardium
whereas isoproterenol elevated the levels of cAMP in all of the
tissues.

The authors concluded that the tissue specificity of

albuterol and terbutaline may have an origin at the level of the
cAMP system (AO).
In studies on isolated venous tissue, Dunham et al. (197^)
showed that prostaglandin E2 (PGE2) and isoproterenol were both
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able to increase cAMP (4l).

Vesin et al.

(1974) however presented

evidence that under certain conditions PGE^ could relax rat myometrium
without increasing levels of cAMP.

Catecholamine induced relaxation

was associated with an increase ii cAMP in this tissue (42).

Thus

smooth muscle relaxation appears ii many instances to be related to
increases in cAMP, although under certain circumstances cAMP independent
mechanisms appear to be involved in relaxation of smooth muscle.
Although tills review has provided evidence that catecholamines
induce smooth rnuscle relaxation via beta adrenergic stimulation of
adenylate cyclase, there are several more criteria set forth by
Sutherland and associates that need to be fulfilled.

Another cri¬

terion was that exogenous cAMP should mimic the effects of the
hormone on the tissue.

Effects of Exogenous cAMP

Moore et a*1. (1968) demonstrated that dibutyryl cAMP (db cAMP)
could produce prolonged relaxation of guinea pig tracheal smooth
muscle.

The relaxation induced by db cAMP could not be blocked by

propranalol (beta blocker) (43).

Dibutyryl cAMP is an analogue of

cAMP which can be added exogenously and has the advantage of membrane
permeability that exogenous cAMP does not have.

In addition db

cAlP inhibits phosphodiesterase and thus results in increases in
intracellular cAMP.
Dobbs and Robison (1968) utilizing uterine smooth muscle
have provided data consistent with the fact that db cAlP and not
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exogenous cAMP could mimic the effects of catecholamines and that these
effects were potentiated by theophylline and not blocked by beta
blocking agents (30).

Triner, Overweg and Nahas (1970) noted epi¬

nephrine-like inhibitory actions of db cAMP (44).
Bowman and Hall (1970) while studying the response of rabbit
intestine to alpha and beta adrenergic stimulation noted the beta
adrenergic-like effects of db cAMP (45).

Andersson and Mohme-

Lundholm (1970) compared the effects of exogenous cAMP and isopro¬
terenol.

Although both compounds could relax intestinal smooth

muscle, at low concentrations, exogenous cAMP could not activate
phosphorylase (31).
Takagi et al. (1971) studied the effects of db cAMP and con¬
cluded that the mechanism of action was related to membrane phenomena
(46).

Scmylo et al.

(1970) showed that both dibutyryl cAMP and

theophylline hyperpolarized the membrane of rabbit pulmonary arteries
at low K+ concentrations and that this change in membrane potential
was associated with relaxation (47).
Pfaffman and McFarland (1973) studied the effects of theophyl¬
line and db cAMP on the phasic and tonic muscular contractions of
guinea pig taenia coli.

Theophylline and db cAMP both inhibited

the phasic contractions while only theophylline inhibited the prolonged
tonic contraction.

The authors concluded that the basis for inhibi¬

tion of phasic contractures was related to mechanisms at the cellu¬
lar membrane level which may inhibit the inward Ca+^ movement re¬
quired for the production of the action potential (48).
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Ohkawa

(1975) also showed that db cAMP inhibited spike potentials and con¬
tractions of cat small intestine.
propranalol (49).

This effect was not blocked by

Thus in many smooth muscles db cAMP appears to

be able to cause relaxation and this effect is not inhibited by
beta-adrenergic blocicing agents.

Methylxanthines

Another of the criteria of Sutherland and associates that
is needed in order to implicate cAMP as a mediator of smooth muscle
relaxation is that phosphodiesterase inhibitors should potentiate
the relaxation of agents that induce relaxation via cAMP dependent
mechanisms.

Kukovetz and Poch (1970) illustrated that methylxan¬

thines inhibit phosphodiesterase in beef coronary arteries and this
ability to inhibit phosphodiesterase activity was related to smooth
muscle relaxation (50).
Lugnier, Bertrand and Stoclet (1972) demonstrated a quantitative
correlation between inhibition of phosphodiesterase activity and
the prevention of rat aortic strip contractions induced by barium
(51).

Many other workers have confirmed the smooth muscle relaxant

effects of the methylxanthines and its relationship with phosphodies¬
terase inhibition (38, 39, 52, 53, 54, 55).
Current evidence basically supports the role of cyclic nucleo¬
tides in smooth muscle relaxation.

There are several studies

which argue against cyclic AMP mediation in relaxation.

Schonhofer

et al. were unable to stimulate adenylcyclase in a cell-free
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preparation of vascular tissue (56).

Vesin and Harbon, as previously

mentioned, have demonstrated that prostaglandin Eunder certain
conditions, was able to relax rat myometrium without raising cAMP
levels (42).

Furthermore, Namm et al. were unable to relax rabbit

aortic strips with either db cAMP or cAMP (57).
Furthermore, Polacek and Daniel (1971) did not observe any
Increase in cAMP levels in rat uteri relaxed with low concentrations
of papaverine, theophylline and diazoxide.

ihey postulated that

the methylxanthines tested did not bring about relaxation by phos¬
phodiesterase inhibition (58).
Generally, the role of cyclic nucleotides on ureteral smooth
muscle relaxation have yet to be extensively investigated.

Potassium

contracted ureteral segments may be relaxed by isoproterenol and theo¬
phylline (59).

Weiss, in a recent study, stimulated adenylate cyclase

activity in a cell-free preparation of rabbit ureter with isopro¬
terenol.

He also was able to inhibit phosphodiesterase activity with

theophylline.

Hie rabbit ureter thus has adenylate cyclase activity

which may be stimulated by beta-adrenergic agonists and phospho¬
diesterase activity which may be inhibited by theophylline.

This

serves as further evidence in favor of the presence of beta-adrenergic
receptors in the rabbit -ureter.

He showed that basal adenylate

cyclase activity was lower in obstructed than in control's segments
of rabbit ureter, although the percent increase in adenylate cyclase
activity was greater in obstructed ureteral segments when isoprotere¬
nol was applied to obstructed and control segments (60).
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In addition, recently Hausmari, Biancani and Weiss (6l) showed
that segments of obstructed rabbit ureters developed a 3-fold greater
contractile force than did control segments in response to electrical
stimulation and that this was greater than that which would have
been expected from muscle hypertrophy alone.

From these data it

would appear that basic changes probably occur at a cellular level
in the obstructed ureter and in part these changes might be related
to the cyclase-phosphodiesterase system.

Therefore, this investi¬

gation was undertaken to study the differential effects of betaadrenergic stimulation on obstructed and control ureteral segments.
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MATERIALS AND METHODS

White New Zealand female rabbits (2-3 kg) were anesthetized
with sodium thiopental (30 mg/kg), intravenously.

Ihrough a 5 cm

midline suprapubic Incision the distal left ureter was identified
and a 4-0 silk ligature was placed around the ureter and a parallel
placed 16 gauge needle which was subsequently withdrawn to create
a partial obstruction.

The suprapubic incision was then closed.

Two weeks after the onset of obstruction, the rabbits were
re-anesthetized with intravenous urethane (1.6 g/kg) and both
ureters were exposed through a midline transperitoneal incision.
Platinum hooks were placed approximately 1 cm apart on the in situ
obstructed and control ureter and secured with 4-0 silk ligatures.
Exact measurement of the in vivo length of the selected ureteral
segments was determined with a calibrated microscopic ocular which
permitted determination of the distance between the hooks.

While the

measurements were being obtained, the ureters were kept moist by
filling the abdominal cavity with tyrodes solution (137 nM NaCl;
12 nM NaHC03; 1.8 mM Nat^PO^; 2.7 nM KC1; 2.7 rrM CaCl2; 0.5 irM
MgCl2; 5.5 nM glucose).
C>2 and 5% C02, at 37° C.

Tyrode solution was equilibrated with 95%
The segments were then excised and placed

in a muscle chamber which was perfused with oxygenated lyrodes solu¬
tion.

Chamber temperature was maintained at 37° C by flow of the

tyrode solution through a glass coil heat exchanger that was heated
by warm water from a constant temperature perfusion pump (Haake).
24

Hie warm water also circulated, through the water-jacket of the
muscle chamber to help maintain a stable temperature.

Temperature

was monitored with a telethermometer and thermistor probe (Yellow
Springs Instruments Co., Inc.).

One end of the segment was affixed

to a stationary platinum hook in the bottom of the chamber and the
other end was attached to a Stathem UC-2 force transducer which
was mounted on a moveable slide assembly which allowed for change
in muscle length.
(Model 7)•

Tension was monitored on a Grass polygraph

The muscle segment was stretched to apply a 500 mg tension

and the new in vitro length was remeasured with a calibrated micros¬
copic ocular.

After a 10 minute equilibration period a tonic

contracture was achieved with a high potassium tyrode solution
introduced into the muscle chamber (105 rrM KC1; 35 nM NaCl; 12 mM
NaHCO^; 1.8 rrM NafhPO^; 2.7 rrM CaCl^; 0.5 irM MgClQ; 5.5 rrM dextrose).
The high potassium tyrode solution was equiosmolar with the standard
tyrode solution.

The perfusion rate (70 ml/min) and temperature

(37° C) were kept constant.

After the level of the high potassium

induced tension development became constant, appropriate concentrations
of various agents were added to the high K+-tyrode solution and the
magnitude of relaxation determined.

Isoproterenol Dose-Response

After obstructed and non-obstrusted ureteral segments were
+
contracted with high K -tyrode solution and the tension development
became stable, the perfusate was changed to high-K+ tyrode solution
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containing 10-^ M isoproterenol.

This solution was perfused for 15

minutes and the magnitude of relaxation recorded.

Normal tyrode

solution was then reintroduced into the chamber and tension further
declined to the resting level.

The segments recontracted with high-

K+-tyrode solution, relaxed with high K+-tyrode containing 10“8 m
isoproterenol and then further relaxed to the resting level with
tyrode solution containing a normal concentration of potassium.
The cycle was then repeated with increasing concentrations of
isoproterenol.

The maximum concentration of isoproterenol employed

was 10“6 M.

Tieophylline Dose Response

Obstructed and non-obstructed 'ureteral segments were contracted
with high K -tyrode solution (105 nM KC1).

After development of a

stable contracture the perfusate was changed to high-K+ tyrode
solution containing 10“9 M theophylline.

After 15 minutes the

perfusate was changed to high K+-tyrode containing 10"^ M theophylline.
Increasing concentrations of theophylline were added during each
subsequent 15 minutes interval until a maximum concentration of 10“^
M theophylline was delivered.

The magnitude of the cumulative

relaxation at each concentration was recorded.

Isoproterenol Dose Response in Presence of Theophylline, 10~5 M

Obstructed and non-obstructed ureteral segments were contracted
with high K+-tyrode solution (105 nM KC1) containing theophylline,
1 X 10“5 M.

After development of a stable contracture isoproterenol
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10 y M was added to the high K -tyrode containing 10 ^ theophylline.
Increasing concentrations of isoproterenol were added during each
subsequent 15 minute interval until a maximum concentration of 10“^
M isoproterenol was attained,

ihe magnitude of the cumulative

relaxation at each concentration was recorded.

Normal tyrode solu¬

tion was then introduced, resulting in further relaxation to the
resting level.

Isoproterenol Dose Response in Presence of Phentolamine, 10

_7

M

Obstructed and non-obstructed ureteral segments were contracted
with high K^-tyrode solution (105 mM KC1) containing phentolamine,
-7

1 X 10 ' M.

After development of a stable contracture, increasing

concentrations of isoproterenol were added to the perfusate at
15 minute intervals, starting at 10

-9

M isoproterenol until achieving

a maximum concentration of 10"^ M isoproterenol.

The magnitude of

the cumulative relaxation at each concentration was recorded.

Nor¬

mal tyrode solution was then introduced resulting in further relaxa¬
tion to the resting level.

2?

RESULTS

Figure 1 shows the relationship between potassium concentra¬
tion and force developed of unobstructed rabbit ureters.
tension development occurred with 70 rrid potassium.

Optimum

A small decrease

in force developed occurred at higher potassium concentration.

The

maximum force developed in response to tyrode solution containing
70 rrM K*, was observed when a 500 mg resting tension was applied
to the non-obstructed ureteral segnents (Fig. 2).
Significant differences in percent relaxation were observed
between obstructed and unobstructed rabbit ureters when exposed to
isoproterenol.

Obstructed ureters were insensitive to beta-adrenergic

stimulation by isoproterenol, 10“9 M.

This was contrasted by the

considerable degree of relaxation which was noted with the unobstructed
ureteral segments at the same isoproterenol concentration (0% obs¬
tructed vs. 52.8 + 8.27%* unobstructed) (P<.0025) (Table I).

All

data are expressed as the mean + the standard error of the mean (SEM).
A similar differential sensitivity to the beta-adrenergic agonist
was noted between obstructed and non-obstructed ureteral segnents with
Q

10

M isoproterenol (2.14 +_ 2.14% obstructed vs. 42.4 +7.0% unobs¬

tructed) (P<).0005).

A further increase in the isoproterenol con¬

centration yielded a similar disparity in terns of percent relaxation
between the obstructed and unobstructed ureteral segments.
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These

differences were 4.07 + 1.8l$ for the obstructed and 49.25 + 19.6$
for the unobstructed segments at 10“7 M isoproterenol (p<.025).
Percent relaxation of the non-obstructed ureteral segments was not
as great at 10“6 M isoproterenol (0$ obstructed vs. 14.0$ unobs¬
tructed) (p<.0005).
The contractile force developed in response to the depolarizing
concentration of potassium differed significantly between the obstructed
and non-obstructed ureteral segments.

In the sample that received

10~9 m isoproterenol the mean contractile force developed of obstructed
ureteral segments was 303.3 +80.89 mg as compared to 153-3 + 28.48
mg for non-obstructed segments (.10<p<.05).

Similar comparisons

of the samples receiving other concentrations of isoproterenol were
as follows:

10“6 m isoproterenol, 320 + 41.36 mg obstructed vs.

150 + 30.4 mg unobstructed (p <.0025); 10“^ M isoproterenol, 281.5
+ 68.58 mg obstructed vs. 98.75 + 43.89 mg unobstructed (p<.025);

10-6 m isoproterenol, 311.25 + 36.95 mg obstructed vs. 77-5 +7.5
mg unobstructed (p<.0005).
To determine whether the differential sensitivity to isopro¬
terenol was due to the greater developed force of the obstructed
ureteral segments, the data shown in Table I were re-analyzed using
data only from those obstructed ureteral segments whose developed
force in response to a depolarizing concentration
was less than 300 mg (Table II).

of potassium

In the sample receiving 10“9 m

isoproterenol the mean contractile force developed was 235 + 75 mg
for obstructed segments vs. 153*3 + 28.48 mg for unobstructed
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segments (p <.15).

The difference in the degree of relaxation

between the two groups was still significant.

0% relaxation was

recorded for obstructed ureteral segments as compared to 52.8 +
8.27% for unobstructed ureteral segnents (p<.005).

The mean conQ

tractile force for segments subsequently receiving 10 ° M isoproterenol
was 250 +19.32 mg for obstructed segnents vs. 150 + 30-40 mg for
unobstructed segments (p<.01) and the degree of relaxation for the
obstructed segments was .23 + .23% vs. 42.2 + 7.0% for the unobstruc¬
ted segnents (p <.0005).
Similar results were obtained for segnents receiving lCT? M
isoproterenol.

The mean contractile force was 165 + 37.9 mg for the

obstructed ureters vs. 98.75 +43.89 mg for the unobstructed ureters
(p<.10).

The percent relaxation was significantly different with

2.78 + 1.79% relaxation for obstructed ureteral segnents as compared
to 49.25 + 19-58% for the unobstructed segnents (p<.025).

Mean

contractile force for segnents subsequently treated with 10~6 M
isoproterenol was 225.0 +32.27 mg for obstructed segnents vs. 77.5
+ 7*50 mg for unobstructed

ureters (p<.01).

At this concentration

of isoproterenol the percent relaxation of the obstructed ureters
was 0% vs. 14 + 0 for the unobstructed ureteral segnents (p<.20).
Thus the differential sensitivity to isoproterenol appears to persist
even when comparing the percent relaxation of unobstructed ureteral
segnents to obstructed segments which developed a lower and more
comparable contractile force in response to high K+-tyrode.
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The response to the cumulative addition of isoproterenol in the
presence of an alpha-adrenergic blocker (lCT? Fhentolamine) is shown
in Table III.

Fhentolamine, 10“^ M did not affect the force of con¬

traction of obstructed and non-obstructed ureteral segments.

A

greater percent relaxation in response to isoproterenol was observed
in non-obstructed than in obstructed ureteral segments in the presence
of a low concentration of phentolamine (Fig. 1 and Table HI).

Mean

contractile force was 342.5 + 105.2 mg for the obstructed segments
and 180 + 60 mg for the unobstructed segments.
tion was as follows:

The percent relaxa¬

10“9 M isoproterenol - 0$ obstructed vs. 24.95

+ 8.35$s unobstructed (p<.025); 10“^ M isoproterenol - 0.005 +
0.0028$ obstructed vs. 33-3 + 0, unobstructed (p<.0005); 10”^ M
isoproterenol - .005 + .0028$ obstructed vs. 48.8+12.5$ unobstructed
(p<.0125); 10"6 M isoproterenol - .005 + .0078$ obstructed vs.
29.15 + 29.14$ unobstructed (p<.15).
The effect of a cumulative addition of theophylline to obstructed
and non-obstructed ureters is shown in Fig. 4 and Table V.

Both

groups relaxed in response to theophylline, however at 10“^ M theophyl¬
line, the percent relaxation was significantly greater in the ncnobstructed ureteral segments.

The high K+-induced contractile

force of segnents subsequently treated with theophylline was 743.33
+ 152.46 mg for the obstructed segnents compared to 162.0 + 42.71
mg for unobstructed segments (p<.005).
both groups was as follows:

The percent relaxation for

10“9 M theophylline, obstructed 1.75

+ 1.75$; 10~8 m theophylline, obstructed 7*23

3.41$ vs. unobstructed

5.92 +3.^2$ (p <.30); 10“7 M theophylline, obstructed 10.73 +
5.28$ vs. unobstructed 17-96 + 9.46$ (p<.20); 10“6 M theophylline,
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obstructed 13.0 + 6.68% vs. unobstructed 30.24 +15-43% (p<.10);

10“6 M theophylline, obstructed 13*85 + 8.32% vs. unobstructed
70.73 + 8.4l% (p<.0005); 10~;t M theophylline, obstructed 10.32
+7.41%; 10"3 M theophylline, obstructed 19-93 + 6.67%.
Comparison of the relaxing effects of thelphylline on unobstructed
ureters and on obstructed ureters that did not contract more than
450 mg in response to a depolarizing concentration of potassium
revealed a similar relationship (Table VI).
Data obtained when obstructed and unobstructed ureteral segments
were initially contracted with high K+-tyrode solution and then
immediately exposed to a 10 3 M concentration of theophylline, "ini¬
tial exposure group" are shown in Table VII.

The results show that

this group which was initially exposed to 10“3 M theophylline showed
a greater percent relaxation than that of those exposed to a high
concentration of theophylline only after a long period of time during
which cumulative increasing concentrations of theophylline were
delivered, "long exposure group" (Table V).

The force developed

in response to high K+-Tyrode solution for segments subsequently
treated with an initial 10-3 M concentration of theophylline was
229.1 + 36.58 mg for obstructed segnents vs. 152.5 + 33.0 mg for
unobstructed segments (.10<p<.05) (Table VII).

The percent relaxa¬

tion among this group exposed initially to 10~3 M theophylline was
51 + 9-26% for obstructed segnents vs. 83.5 +2.90% for unobstructed
segnents.

A comparison between the "long exposure" and the "initial

exposure" groups of obstructed ureters reveals that in terms of percent
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relaxation the initial exposure group relaxed to a greater degree.
The mean relaxation in response to 10“^ M theophylline for obstructed
segments in the "long exposure group" was 19*90 + 6.66% vs. 51.0
+ 9.26$ for obstructed segments in the "initial exposure group"
(PC.025).
The effect of 10-5 M theophylline on force developed in response
to high K+-tyrode solution is shown in Table VIII.

Obstructed and

unobstructed ureters were contracted with a high Resolution containing
10~5 M theophylline.

Obstructed ureters exposed to high Resolution

in the presence of 10“^ M theophylline contracted more than did
obstructed ureters in the absence of theophylline.

No significant

difference was noted with unobstructed ureters contracted in the
presence or absence of 10“^ M theophylline.

Contractile force

developed of obstructed ureteral segments in the presence of 10“^ M
theophylline was 571.66 + 91.26 mg vs. 321.23 + 83-53 mg for obstructed
segments in the absence of theophylline (p <.025).

Contractile force

developed of unobstructed ureters in the presence of 10

-5

M theophyl¬

line was 116.66 + 3I.8 mg vs. 155-55 +_ 27.18 mg for the unobstructed
segments in the absence of theophylline (p<.15).
Obstructed ureters contracted with a high K+-solution containing
10M theophylline were subsequently exposed to increasing cumulative
concentrations of isoproterenol.

Isoproterenol was able to relax

ureters contracted in the presence of

10-5 m

theophylline (Table

IX).

This was in contrast to the insensitivity to isoproterenol noted
when obstructed, ureteral segments were contracted in the absence
of theophylline (Table I).

Percent relaxation of obstructed ureteral
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segments contracted and perfused in the presence of 10
line was as follow:

„5

M theophyl¬

3.24 + 2.08$ with 10“^ M isoproterenol; 10.25

+ 3.55% with 10“8 M isoproterenol; 23.98 + 4.39$ with 10""'7 M isopro¬
terenol; and 23.43 + 9-12% with 10”^ M isoproterenol.
To aid in the interpretation of these data, prelirrdnary biochemical
studies of the effect of obstruction on the cyclase-phosphodiesterase
system of the ureter were initiated (Table X).

Basal ureteral

adenylate cyclase activity was lower in obstructed than in nonobstructed ureteral segments.

A mean of 1,766 pmoles of cAMP were

formed/rrg protein/5 minutes for obstructed ureteral segments as
compared to 1,009 pmoles cAMP formed/mg protein/5 minutes for the
non-obstructed ureters.

Addition of NaF to the assay mixture resulted

in an increase in adenylate cyclase activity; 2,99^.3 pmoles cAMP
formed/mg protein/5 minutes for unobstructed segments and 2,024.8
pmoles cAMP formed/mg protein/5 minutes for obstructed ureters.
Isoproterenol, 10 ^ M, activated adenylate cyclase activity in
obstructed and unobstructed ureteral segments.

In unobstructed

ureters, 2,016.5 pmoles cfflP were formed/mg protein/5 minutes whereas
1,446 pmoles cAMP were formed/mg protein/5 minutes in obstructed ure¬
ters.

This represented a 13-5$ increase above basal activity for

unobstructed ureters vs. 43.3% increase above basal activity for
obstructed ureters (Table X).
In two experiments performed on pooled samples of ureters, basal
endogenous cAMP levels were 17-32 and 18.91 pmoles/mg protein in
unobstructed ureters and 22.50 and 30.24 pmoles/mg protein in
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obstructed ureters.

Incubation of the ureters in 2 X ICf^ M iso¬

proterenol for 90 sec resulted in an increase in cAMP in unobstructed
ureters to 32.08 and 21.58 pmoles/mg protein whereas in obstructed
ureters ciMP levels remained relatively unchanged at 23.08 and 15.27
pmoles/irg protein.

Theophylline, 10

-2

M, caused an increase in cAMP

levels of a pooled sample of unobstructed ureters form 18.91 to 86.24
pnoles/mg protein and a moderate increase in cAMP in a pooled sample
of obstructed ureters from 30.24 to 36.88 pmoles/mg protein.
line, 10

-2

Theopbyl-

M, potentiated the increase in cAMP caused by isoproterenol.

Endogenous cAMP levels were 49-38 and 83.33 pmoles/mg protein in
obstructed and unobstructed ureters, respectively, that were incubated in 2 X 10

—6

0

M isoproterenol and lO-^ M theophylline.

After

incubation In 10”^ M theophylline and 5 X 10"^ M isoproterenol the
endogenous levels of cAMP were 72.50 and 119.89 pmoles/mg protein
in obstructed and unobstructed ureters, respectively.
Phosphodiesterase activity was less in obstructed than in
unobstructed ureters.

Figure 6 shows a Hofstee plot of the kinetics

of cAMP-phosphodiesterase activity in obstructed and non-obstructed
ureters.

The Km’s were similar in obstructed and non-obstructed

ureters; however, the

was greater in unobstructed than in

obstructed ureters.
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DISCUSSION

Hausman, Biancani and Weiss (6l) showed that ureteral obstruc¬
tion altered ureteral contractility. The magnitude of ureteral
contractions in response to electrical stimulation was 250% greater
in obstructed than in unobstructed ureters and this increase in
active tension could not be explained by muscular hypertrophy, alone.
Weiss and associates (60) also denDnstrated that the rabbit ureter
has beta-adrenergic receptors and an adenylate cyclase-phosphodies¬
terase system.

The present study was undertaken to examine the

effect of obstruction on beta-adrenergic induced relaxation of the
ureter and to correlate these effects with changes in the cyclasephosphodiesterase system.
The most significant finding of this study was the insensitivity
of obstructed ureters to beta-adrenergic stimulation.

Isoproterenol,

10-9 to 1CT6 M had very little relaxant effect on obstructed ureteral
segnents, although the same concentrations of isoproterenol were
able to relax unobstructed ureters.
A possible complicating factor in comparing the relaxant effects
of isoproterenol on obstructed and unobstructed ureteral segnents
was tbe significantly greater force developed of obstructed ureters
in response to high K* solutions.
finding of Hausman et al.

This was in accord with the

(6l), that obstructed rabbit ureters

developed a greater force in response to electrical stimulation
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than did unobstructed ureters.

One can argue that this greater active

force development by the obstructed ureters may have masked the
relaxation induced by beta-adrenergic stimulation.

Table II shows,

however, that the differential sensitivity to isoproterenol was
still evident when comparing beta-adrenergic induced relaxation of
unobstructed ureters with relaxation of obstructed ureters that
developed less than 300 mg of contractile force.

With this method

of sampling, force developed by obstructed and unobstructed ureters
in response to a depolarizing concentration of potassium was not
significantly different in ureters that were subsequently treated
with 10“9 and 10“^ M, isoproterenol.

Contractile force of obstructed

ureters that subsequently were treated with 10

-R

and 10

-3

M iso¬

proterenol was still significantly greater than that of unobstructed
ureters treated with equal concentrations of isoproterenol.

Perhaps

more comparable samples would have been achieved if a lower maximum
contractile force of obstructed ureters had been used in Table II,
but this would have limited too severely the number of segments
available for comparison.

In the future it might prove useful to

compare relaxation of unobstructed ureters with that of obstructed
ureters contracted with a lower concentration of potassium.

This

would hopefully further eliminate the inequalities of force developed
by obstructed and unobstructed ureters and thus provide for more
comparable samples for comparing the relaxing effects of isopro¬
terenol on obstructed and unobstructed ureteral segments.
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Although isoproterenol is primarily a beta-adrenergic agonist,
it does have some alpha-adrenergic stimulating activity (62).

In

order to eliminate the potential antagonistic effects of alphaadrenergic stimulation on relaxation, an isoproterenol dose response
curve in the presence of 10“^ M phentolanrme was used to evaluate
"pure" beta-adrenergic responses of obstructed and unobstructed
ureters.

The results demonstrated that even with alpha-adrenergic

blockade, isoproterenol could not relax obstructed ureters.

Con¬

versely, the unobstructed ureters were relaxed by isoproterenol
in the presence of 10~7 M phentolamine (Table III, Fig. 3)That the obstructed ureter could be relaxed ms demonstrated by
the finding that theophylline was able to relax the obstructed
ureter (Table V, Fig. 4), although this relaxation was less than
that observed with unobstructed ureters.

The percent relaxation

with the addition of 10”^ M theophylline was 51 + 9.26% for obstructed
ureteral segments and 83-5 +2.9% for

unobstructed ureters (Table VII).

If isoproterenol induced relaxation of ureteral smooth muscle
is related to an increase in cAMP, it would be possible that the
insensitivity of obstructed ureters to beta-adrenergic stimulation
inigjit be due to an increased phosphodiesterase activity in the
tissue.

Thus the effect of a cumulative addition of isoproterenol

to obstructed ureters previously contracted in the presence of
10“^ M theophylline, was studied.

In the presence of 10"^ M theophyl¬

line, isoproterenol was able to cause relaxation of the obstructed
ureter.

The percent relaxation induced by isoproterenol in obstructed
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ureteral segments was:

3*24 + 2.08% at 10

-9

M isoproterenol;

10.25 + 3.55% at 10“8 M isoproterenol; 23*98 + 1.39% at

10“ ?

M

isoproterenol; and 23.13 +9.12% at 10“^ M isoproterenol (Table IX,
Fig. 5).

This degree of relaxation was significantly greater than

that resulting from the cumulative addition of isoproterenol to
obstructed ureteral segments in the absence of theophylline (Table
I).

However, the percent relaxation resulting from the addition

of isoproterenol to obstructed segments contracted and perfused
in the presence of theophylline was significantly less than the
relaxation resulting from the addition of isoproterenol to unobstructed
ureteral segments (Table V).

These latter experiments on unobstructed

ureters were not done in the presence of theophylline, but such
studies would only be expected to exaggerate the differences already
observed.

From these sets of experiments it would appear that the

phosphodiesterase inhibitor, theophylline, may potentiate the
relaxing effects of isoproterenol on obstructed ureteral segments;
however, the relative insensitivity of obstructed ureteral segments
to beta-adrenergic induced relaxation may be demonstrated whether
or not the phosphodiesterase inhibitor is added to the perfusate.
The relative insensitivity of obstructed ureteral segments to
isoproterenol thus does not appear to be entirely due to an increased
phosphodiesterase activity in the obstructed segments.
Biochemical studies were thus undertaken in our laboratories
by Weiss, Vulliemoz, Verosky and Triner to provide insight into
the reasons for the mechanical evidence of a relative beta-adrenergic
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receptor insensitivity of the obstructed 'ureters.

In accord with

the data obtained from the mechanical studies, basal adenylate
cyclase activity was lower in obstructed ureters than in unobstruct¬
ed segments (1,009 pmoles cAMP/mg protein/5 min for obstructed
vs. 1,776 pmoles cAMP/mg protein/5 min for unobstructed) (Table X).
Even in the presence of NaF activation cf adenylate cyclase
the unobstructed levels remained higher than the obstructed levels:
2,994.8 pmoles cAMP/mg protein/5 min for unobstructed ureters vs.
2,02*1.8 pmoles cAMP/mg protein/5 min for obstructed ureters.
Isoproterenol 10-^ M stimulated adenylate cyclase activity.

The

mean amount of cAMP formed rose from 1,776 pmoles/mg protein/5
min to 2,016.5 pmoles cAMP/mg protein/5 min in unobstructed ure¬
ters (13.5$ increase) and from 1,009 pmoles cAMP/mg protein/'5 min
to 1,446 pmoles cAMP/mg protein/5 min in obstructed ureters (43•3%
increase).

Although NaE and Isoproterenol caused a larger percent

increase in cyclase activity in obstructed than in unobstructed
ureters, the total activity in these stimulated specimens was still
lower in the obstructed ureters.
The lower basal levels of adenylate cyclase activity in obs¬
tructed ureters and the lower total activity in obstructed ureters,
even after beta-adrenergic stimulation, are in accord with the
decrease percent relaxation resulting from isoproterenol applica¬
tion to obstructed ureters.

Although these measures of total

adenylate cyclase a.ctivity were lower in obstructed ureters, iso¬
proterenol caused a larger percent increase in adenylate cyclase
activity above basal levels in the obstructed samples.
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Thus although

the obstructed ureter relaxes less in response to isoproterenol,
it does possess adenylate cyclase activity which is responsive
to beta-adrenergic stimulation.
If isoproterenol induced relaxation of ureteral smooth muscle
is mediated by cAMP, then an increase in endogenous cAMP might be
observed in segments treated with isoproterenol.

In addition,

it was thought that obstructed ureters which have a lower adenylate
cyclase activity and which are less sensitive to the relaxing
effects of isoproterenol might demonstrate a smaller increase in
cAMP after incubation with isoproterenol.
Preliminary studies on several ureters seem to indicate that
90 seconds of incubation with isoproterenol causes a moderate
increase in cAMP levels in unobstructed ureters and has little
effect on cAMP levels in obstructed ureters.

These data correlate

with the observed effects of isoproterenol on ureteral smooth
muscle relaxation.

Factors such as time of incubation in iso¬

proterenol and breakdown of cAMP by phosphodiesterase effect the
measurements of these levels and further experiments will be
required.

In one preliminary study phosphodiesterase inhibition

with theophylline potentiated the isoproterenol induced rise in
cAMP in both obstructed and non-obstructed ureters.

The endogenous

cAMP levels, even under these conditions remained lower in the
obstructed than in the unobstructed ureters.

Thus these preliminary

studies of changes in cAMP correlate well with the observed relaxing
effects of these agents on the obstructed and unobstructed ureters.

Studies of phosphodiesterase (PDE) activity of obstructed and
non-obstructed ureters were undertaken to determine whether dif¬
ferences in PDE activity might account for the insensitivity of
obstructed ureters to isoproterenol.

Theophylline had increased

the magnitude of the isoproterenol induced relaxation of obstructed
ureters, although not to the degree noted with unobstructed ureters.
An increased PDE activity in obstructed ureters might account for
the lower cAMP levels in obstructed ureters after isoproterenol
application and the lesser degrees of relaxation.

However, this

appears not to be the case since the obstructed ureter has a de¬
creased cAMP PDE activity in comparison to the non-obstructed
ureter.

Kinetic studies showed that the Km of both obstructed

and unobstructed ureters were similar, but the
structed segments was greater.

of the unob¬

An increased PDE activity thus

does not appear to be the cause of the decreased sensitivity of
obstructed ureters to isoproterenol.
The biochemical data supports the mechanical evidence that ob¬
structed ureters are less sensitive to isoproterenol than are unob¬
structed ureters.

The major problem is in elucidating the defect

in the relaxation process of the obstructed ureteral smooth muscle.
It is possible that there is some defect in the beta-inhibitory
receptor site on the obstructed ureter which accounts for the
reduced ability of isoproterenol to stimulate adenylate cyclase
and cause relaxation.

Adenylate cyclase is in close apposition

to the receptor site and the defect may also lie in the link between

the receptor and adenylate cyclase.
Since adenylate cyclase activity of obstructed ureters may
be stimulated by isoproterenol and NaF, the receptor-adenylate
cyclase system must be present in the obstructed ureters.

The

exact mechanism for the higher percent increase in activation of
adenylate cyclase by these agents in obstructed ureters and the
total decrease in activity in this tissue is not apparent.

An

increased phosphodiesterase activity is surely not accounting for
the decreased sensitivity of obstructed ureters to isoproterenol
induced relaxation.

Although 10

_2

M theophylline increased the

ability of isoproterenol to relax the obstructed ureter, the percent
relaxation was still less than that noted in the non-obstructed
ureter.

In addition, preliminary studies suggest the presence of

a decrease in cAMP-PDE activity in obstructed ureters.

This de¬

crease might be due to the fact that since the obstructed ureter
has a decreased adenylate cyclase activity and less cAMP is formed
in response to isoproterenol, a lesser amount of PDE activity
is required to hydrolyze the available cAMP.

Furthermore, it is

conceivable, although probably unlikely, that compartmentalization
of PDE in the obstructed ureter might lead to an increased activity
in the vicinity of the cAMP, but yet a decreased overall activity.
One could thus argue that compartmentalized pools of PDE are of
sufficient quantity to break down cAMP produced by a malfunctioning
receptor-adenylate cyclase.
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It is possible that part of the beta-inhibitory adrenergic
insensitivity of obstructed ureters may be due to a partial defect
in the receptor-adenylate cyclase link.

Therefore the obstructed

ureters will have depressed tissue levels of cMP and the low
phosphodiesterase enzyme activity, which might be compartmentalized,
is still sufficient to break down cAMP below a "threshold" level
that is required for relaxation.

When high doses of isoproterenol

were added in the presence of theophylline, sufficient cAMP might
have been produced to promote relaxation.
The decreased adenylate cyclase activity in obstructed ureters
suggests that there is an intracellular biochemical defect accounting
for the relative insensitivity of obstructed ureters to isopro¬
terenol-induced. relaxation.

However, it must be kept in mind that

the ultimate defect in the obstructed ureter may be at the level
related to changes in the distribution of intracellular calcium.
This work and the studies of Hausman et al (6l) show that in
addition to the insensitivity to isoproterenol-induced relaxation,
the obstructed ureter develops a greater force with electrical or
high-K+ stimulation.

Both the alteration in relaxation and in

contraction may be due to alterations in calcium fluxes within the
cell.

It does not appear that a purely mechanical explanation can

account for the insensitivity of obstructed ureters to beta-adrener¬
gic induced relaxation, since both obstructed and unobstructed
ureters were relaxed to control resting tension when the perfusate
was changed to a normal tyrode solution.
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Additional studies are needed to further elucidate the betaadrenergic insensitivity of the obstructed ureters.

The effect

of exogenous db cAMP would provide further evidence to meet Suther¬
land's criteria as to whether ureteral smooth muscle relaxation
was mediated by cAMP.

The relative sensitivity of obstructed and

unobstructed ureters to db cAMP would help define the location
of the defect in the relaxation process of obstructed ureteral
smooth muscle.

Hie efficacy of beta-adrenergic blockade with

propranolol to alter the differential response to isoproterenol
perhaps would aid in localizing the nature of the defect in obstructed
ureters.

Direct assay of beta receptors of obstructed ureters

would be necessary to investigate any alteration of the receptor
site.

Furthermores studies of Ca++ fluxes in obstructed and unob¬

structed ureters might provide insight into whether differences
++
in the sequestration of Ca
by the sarcoplasmic reticulum might
account for observed alterations in ureteral contraction and re¬
laxation .
The results of this study indicate that there exist alterations
in the basic physiologic mechanism governing smooth muscle relaxa¬
tion of obstructed ureteral muscle.

Further experiments previously

outlined would greatly enhance the elucidation of the mechanism
involved in the obstructed ureters insensitivity to beta-adrenergic
stimulation.
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TABLE I
mg contraction

mg relaxation

%

obst
unobst
3
3
303.3
153-3
140.1
49.3
+80.89 +28.48
1.748
<.10 >.05

obst
3
0
0
0

obst
3
0
0
0

10
7
320
150
130
80.4
+41.36 +30.4
3.29
<.0025 >.0005

10
6
18.97
+6.0

Isuprel
n
mean xl
SD
SE
t (ob vs unob)
P

10
4
281.5
98.75
216.87
87.78
+68.58 +43.89
2.24
<.025 >.01

10
13.00
21.10
+6.6 7

10 ^ Isuprel
n
mean S3
SD
SE
t (ob vs unob)
P

8
2
311.25
77-5
104.53
10.6
+36.95
+7-5
6.20
< .0005

Isuprel alone
10

isuprel

n
mean 3a
SD
SE
t (ob vs unob)
P
_o
10
Isuprel
n
mean xi
SD
SE
t (ob vs unob)
P
10

relaxation

unobst
3
76.6
5.77
+3.33
-23.0
.0005

7
62.0
36.8
+13-9
-3.75
<.0025 >.0005

<.0025

unobst
3
52.8
14.3
+8.27
-6.38
>.0005

10
7
2.14
42.4
6.76
18,5
+2.14
+7.00
“5.‘19
< . 0005

_7

4
35-00
19.14
+9.57
-1.88
<.05 >.025

8
0
0
0
0

CM•
V

2
10.00
14.14
+10.00
-1.00
>.15

h
10
49.25
4.07
5.73
39.17
+1.811
+19.58
-2. 30
<.025 >.0125

8

2
14.00
.006
.006
0
0
.0001
7647
<.0005

TABLE II
Isuprel Dose Response

2
235
75
75

3
153.3
49.3
+28.48

1.017
<.20 >.15

0

10'"° Isuprel
n
mean xn
SD
SE
t

P
10'"7 Isuprel
n
mean xi
SD
SE
t
P
10'"6 Isuprel
n
mean xt
SD
SE
t

P

6
7
250
150
80.4
^7-33
+30.40
19.32
2.756
<.01 >.005
4
7
165
98.75
87.78
93
L43.89
+37-9
l.l4l"
<•15 >.10
2
4
225.0
77.50
10.60
64.54
+7.50
+32.27
4.451
<.01 >.005

IB
2
3
76.66
0
0
5.77
0
+3.33
-23 .00
< .0005
2B
6
7
10
62.0
36.8
22.36
10.00 +13.9
"3. 0B3
< .01 > .005
3B
4
7
35.0
4.28
7.86
19.14
+9.57
+2.97
-3. 06
<.01 .
4B
4
0
0
+0

0
0

10"'9 Isuprel
n
mean wr
SD
SE
t
P

obst
unobst
mg relaxation

VJ1

obst
unobs t
mg contraction

300 mg vs Total Population of

V

Low Contractile Force Obstructeds
Unobstrueteds

2
10
14.14
+10
-1. 00
<.20 >.15

obst
unobst
% relaxation
1C
2
0
0
0

3
52.8
14.3
+8.27

-6.38
<.005 >.(D025
2C
6
7
42.4
.23
18.5
.47
+7.00
+ .23
-6.03'7
<.0005
3C
4
7
2.78
49.25
39.17
4.75
+19.58
+1.79
-2.36
<.025 > .0125
4C
4
0
0
0
-1.00
<.20 >.:15

2
14
0
0

TABLE III
Isuprel Dose Response in the Presence of Phentolamine
mg contraction
obst
unobst
4.0
2.0
180.0
3^2.5
210.4
8.48
+10.52
+6.00
1.34
<.15 >.10

n
mean x^
SD
SE
t
P

%

obst
4
.005
.005
.0028

n
mean
SD
SE
t
P

%

relaxation

-8M
unobst
2
33.3
0
+0

< .0005

relaxation

n
mean xj
SD
SE
t
P

-6M

obst
unobst
4.0
2.0
.005
29-15
.005
41.23
+29.14
.0028
-1.00
<.20 >.15

%

~7M

relaxation

obst
4.0
0
0
0

-9M
unobst
2.0
24.95
11.80
+8.35

-2.98
<.025 >.0125

%

relaxation

obst
4.0
.005
.005
+.0028
-3.66
<.0125 >.01

-7M
unobst
2.0
45.8
17.68
+12.50

TABLE IV

Theophylline alone
mg contraction

n
mean x
SD 1
SE
t (ob vs unob)
P

obst
6
626.66

unobst
5

obst

158.00

131.67
248.55

322.34
100.09
+131.60
+44.77
3-37
<.025 >.0125
-9M Theophylline
Relaxation

n
mean X1
SD
SE
t (ob vs unob)

5
26.00
39.74
+17.77

SD
SE
t (ob vs unob)

7.00

108.57
80.71
30.50

—8T4 Theophylline
Relaxation
5
12.00
8.36
+3.74

-5M Theophylline
Relaxation
6
3
25.00
73.33
36.40
35.19
+16.27
+20.27
-1.89
LP\
O

40.82
+16.66
1.09
<.20 >.15

-3M Theophylline
Relaxation
n
mean

13.10
21.93
+8.96

A
0
■—1
V*

t (ob vs unob)
P

6

unobst

6

+101

80.60

-3M Theophylline
total
% relaxation
obst

+32.90
1.097
<.20 >.15

-6m Theophylline
Relaxation

23.33

unobst

6

6
48.33

6
13.33
24.22
+9.88

P

n
mean
SD
SE

—3M Theophylline
total
mg relaxation

-7M Tneophylline
Relaxation
6
35.00
61.23

5
18,00
21.68
+9.69

+25.00
.633
<.30 > .25

-4m Theophylline
Relaxation
6
0
0
0

TABLE V

Cumulative Theophylline Dose Response
mg contraction
Obst,
Unobst

relaxation - cumulative

!
O
1-1
Obst
n

mean xT*
SD
SE

Theophylline
Unobst

6.0
1.75
4.28
+1.75

10_6M Theophylline
n

t
P

6.0
13.03
16.37

SD
SE
t

5.0
30.24
34.50

+6.68
+15.43
-1.0234 ‘
< .20 >.10
10

n
mean xr

ft

10
Obst

6.0
7.23
8.34
+3.41

6.0
10.73
12.94
+5.28

5.0
5.92
7.66
+3.42

.272
<.40 >.30

t
P

mean xl"
SD "
SE

—

10 M Theophylline
Obst
Unobst

6.0

19.93
16.32
+6.67

Theophylline

10

Theophylline

6.00
13.85
20.38
+8.32

3.00
70.73
14.57
+8.41
-4.80“
<.0005

Theophylline
Unobst
5.0
17.96

21.17
+9.46

-.667

10
6.00
10.32
18.16
+7.41

V

%

0

t
P

6.0
5.0
162.00
743-33
95.50
373.45
+152.46
+42.71
3.67
>.1
<•005

A
00

n

mean x7~
SD 1
SE

20

Theophylline

TABLE VI
Low Contraction Theophylline Dose Response

%

Relaxation - Cumulative

mg contraction
obst
unobst
3
450.0
226.05
130.51

5
162.0
95.50
42.71
2.097
<.l >.05
%

relaxation

t
P
10"Theophylline
n
mean xl
3D

SE
t
P

5.0
30.24
34.49
+5.26
15.43
-1.531
<.2 >.l
3.0
5.26
9.12

10

n
mean x7
SD
SE
t

-3

M Theophylline

3.00

9.63
11.38
+6.57

—1

SD
SE

3.0
3-50
6.06
+3.50

1

n
mean -xr

cdF
1
0

10“9]v[ Theophylline
obst
unobst

obst

Theophylline
unobst

3.0
5.27

5.0
5.92

7.05

7.65

+3.42
+5.27
-0.1040
<•9
1

Cumulative

O

n
mean xt
SD
SE
t
P

3.0
1.76
3.06
+1.76

Theophylline
3.00
70.73
14.57
+8.41
-8.0214
<.001

10
obst

Theophyl.
unobst

5.00
3.00
5.27
17.96
21.14
9.12
5.26
+9.46
-1.172
<.2 :>.l
10“
3.00
0
0
0

Theophyl.

TABLE VII
Initial Exposure to -3M Theophylline
mg contraction
n
mean
SD
SE
t
P

xl

Obstructeds
7.0
229.1

Unobstructeds

~T.O
152.5
66.02
+33.0

96.77

+36.58
1.555
<.10 >.05

mg relaxation
n
mean x7
SD
SE
t
P

%

7.00
107.1
42.31
+15.99

4.0
125.0

45.09
+22.54
-.645
<•30 >.25

relaxation
n
mean x7
SD
SE
t
P

n
mean x-.
SD
SE
t
P

5.80
2.90
-3.348
<.005

Comparison

I relaxation

4.00
83.5

7.00
51.0
24.51
+9.26

relaxation between long exposure -3 vs
initial exposure ~ obstructeds
long exposure - obst
initial exposure - obst
%

6.0
19.90
16.32
+6.66

7.00
51.0
24.5
+9.26
2.12
-2.72
<.025 >.0125
-

TABLE VIII
Effect of -5M Theophylline on Tonic Contraction

mg contraction

n
mean xr
SD 1
SE
t
P

mg contraction

n
mean -xr
SD
SE
t
P

Obstructeds - KC1 without
Theophylline

Obstructeds - KC1 with
-5M Theophyl.

13.0
321.23
301.17
+83.53

6.0
571.66
223.55
+91.26
2.02
<.025 >.0125
-

Unobstructeds - KC1 without
Theophylline

Unobstructeds - KC1 with
-5M Theophyl.
3.00
116.66
60.27
+34.8

9-00
155.55
81.56
+27.18

.880
<.20 >.15

TABLE IX
Isoproterenol Dose Response in the Presence of ~5M Theophylline
(Obstructed Ureter)

mg contractions
n
mean xl
SD
SE

6.0
571.66
223.55
91.26

~9M Isoproterenol with -5M Theophylline (Obstructed Ureter)

n
mean xT
SD
SE

mg relaxation
~6700
25.00
41.83
+17.08

cumulative

%

relaxation

~67ocP
3.24
5.09
+2.08

-8m Isoproterenol with -5M Theophylline (Obstructed Ureter)
n
mean xT
SD
SE

6.00
65.00
40.86
+16.68

6.00
10.25
8.69
+3-55

-7M Isoproterenol with -5M Theophylline (Obstructed Ureter)
n
mean xr
SD
SE

6.00
76.67
36.36
+16.26

6.00
23.98
10.76
±4.39

-6M Isoproterenol with -5M Theophylline (Obstructed Ureter)
n
mean x=r
SD
SE

6.00
40.00
63.25
+25.82

6.00
23.43
22.35
+9.12

TABLE X

Adenylate cyclase activity
Controls3

(P moles cAMP/mg protein/5 min)
NaE

%

Inc.

10 ^ Isoproterenol

%

Inc

unobstructed ave.

1,776

2,994.8

+68.6

2.0165

+13.5

obstructed ave,

1,009

2,024 .8

+100.7

1.446

+43.3

Endogenous cAMP (P moles/mg protein)
unobstructed
Control

17.32

18.91

Isoproterenol 2 X 10“^M

32.08

21.58

Isoproterenol 5 X 10~^M

26.82

-5,
Isoproterenol 1 X 10 iYI

16.79

obstructed
20.49

28.24
19.44

22.50

30.24

23.08

15.27

21.65

20.97

22.16

18.69

Control

18.91

30.24

Theophylline 10

86.24

36.88

Theophyl 10”^M + Isoprot. 2 x io_6m

83-33

49.38

Theophyl 10“

+ Isoprot. 5 X 10_6M

119.89

72.50

Theophyl 10“

+ Isoprot. 1 X 10_5M

47.10

47.10

24.93

27.53
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